Shanghai Composite Nears Positive Territory, Pharmaceutical Stocks Surge, Computing Hardware Stocks Continue to Adjust, HSI Fluctuates Higher, New Consumption Concept Stocks Rebound, POP MART Rises 2%Wallstreetcn·Mar 27 at 03:46 AM688302-4.88%600513+9.97%
The A-share innovative drug sector surged in the afternoon, with WECOME rising over 15%, Frontier Biotechnologies and SHANGHAI YIZHONG rising over 10%, and JLPC, Hongbo Pharmaceutical, Genrix Bio, and Chengda Pharmaceutical following suitWallstreetcn·Jan 8 at 11:26 PM300878-4.08%688221-9.38%
JLPC: The net profit for the third quarter was 4.9662 million yuan, a year-on-year decrease of 83.34%Zhitong·Oct 24, 2025 at 04:12 AM600513+9.97%
JLPC: Wholly-owned subsidiary plans to purchase assets, transaction price is 74.5 million yuanZhitong·Sep 12, 2025 at 04:57 AM600513+9.97%
JLPC's subsidiaries sign strategic cooperation agreementsZhitong·Sep 11, 2025 at 04:58 AM600513+9.97%
JLPC has obtained the drug registration certificate for Famotidine InjectionZhitong·Sep 5, 2025 at 03:45 AM600513+9.97%
JLPC: Benzenesulfonic Acid Amlodipine Tablets Complete Drug RegistrationZhitong·Sep 4, 2025 at 04:08 AM600513+9.97%
High-priced stocks continued to decline in the afternoon, with multiple stocks including JLPC hitting the limit downZhitong·Aug 21, 2025 at 12:45 AM600513+9.97%002536-10.00%
The chemical pharmaceutical sector fluctuated and weakened, with TIBET AIM PHARM hitting the limit down, followed by Lifeon Pharmaceutical, JLPC, huahaipharm, Foyou Pharma, and CHENGYIPHARMAZhitong·Aug 20, 2025 at 09:08 PM002826-3.00%003020-2.83%
JLPC: The newly built oral solution production line No. 1 has passed the drug GMP compliance inspection for the first timeZhitong·Aug 19, 2025 at 04:07 AM600513+9.97%
Innovative drug concept rebounds after hitting the bottom, Junshi Biosciences and others rise over 5%Zhitong·Aug 7, 2025 at 09:29 PM002020-2.02%300436-3.47%
JLPC: The LH-1801 project is expected to have no significant impact on the company's revenue and operating performance for a considerable period in the futureZhitong·Aug 5, 2025 at 05:58 AM600513+9.97%
JLPC's subsidiary Lincomycin Hydrochloride Injection has passed the consistency evaluation of generic drugsZhitong·Aug 4, 2025 at 04:22 AM600513+9.97%
The concept of innovative drugs remains active, with Xintian Pharma and others hitting the daily limitZhitong·Jul 31, 2025 at 08:42 PM002287+1.06%600513+9.97%
JLPC: Felodipine tablets pass the consistency evaluation for generic drugsZhitong·Jul 21, 2025 at 04:29 AM600513+9.97%
